Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial

Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Page content remains unchanged; only minor formatting and layout tweaks were observed without altering study details such as eligibility criteria, outcomes, or contacts. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:21:36.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    3%
    Check dated 2025-10-05T10:15:20.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 (Deletions) to v3.1.0 (Additions).
    Difference
    0.1%
    Check dated 2025-09-28T03:16:05.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Updated the page to Revision: v3.0.2, replacing the previous v3.0.1. The 'Back to Top' element was removed as part of the change.
    Difference
    0.2%
    Check dated 2025-09-13T17:36:18.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-06T15:00:44.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with specific medical terms related to myelodysplastic syndrome and associated treatments, while removing several previous terms related to diseases and treatment classifications.
    Difference
    3%
    Check dated 2025-08-30T11:47:25.000Z thumbnail image

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.